Saint-Prex, Switzerland, October 23, 2023—LAGOSTA S.A. announces that it has entered into a collaboration with the global science and technology company Merck
LAGOSTA to supply chitosan for biomedical industry through the Life Science business of Merck
Saint-Prex, Switzerland, October 23, 2023—LAGOSTA S.A. announces that it has entered into a collaboration with the global science and technology company Merck for the distribution of LAGOSTA’s unique chitosan through their Life Science business’ industry-leading eCommerce platform. The compound can be used by pharma, biotech and the biomedical industry for R&D use only, in drug delivery applications, 3D bioprinting and medical devices.
Under the agreement, the Life Science business of Merck will employ its sales, marketing and eCommerce expertise, and leverage the strength of its relationships with the scientific community, to present and distribute LAGOSTA’s premium chitosan. For more information go to www.sigma-aldrich.com
